MTAR IPO Subscription Status

Last updated on May 9th, 2021 at 10:07 am

MTAR Technologies IPO opens today on 3rd March 2021 with a price band of Rs 574-Rs 575. The IPO closes on 5th March 2021. The company develops and manufactures high-precision components and equipment in the clean energy, nuclear, and space, and defense sectors in India and abroad.

The company proposes to utilize the net proceeds from the fresh issue towards repayments of borrowings by the company, funding working capital requirements, and for general corporate purposes.

Pre offer equity shares as of the date of RHP were 28,611, 442 equity shares, and equity shares outstanding after the offer would be 30,759, 591. MTAR IPO Subscription Status

Strengths

• Wide product portfolio.
• It has established trusted and long-standing relationships with its customers.
• Decent financial performance

Challenges

• Client concentration risk
• IPO valuations seem to be stretched at a higher side.
• Budgeted defense expenditure may witness constraints in FY21 largely due to COVID- 19 pandemic.
• Though profits are reasonable they have been quite inconsistent as can be seen from the trend in the margins.

The GMP of the IPO is trading at a 43% premium over its offer price as per the data available.

Subscription Details

MTAR IPO Subscription Status [in no. of times (x)]

[su_table]

[/su_table]

Important Dates of MTAR IPO Allotment and Listing 

Related Posts

Upcoming IPOs in Year 2021

• About
• Latest Posts

CA Priyanka Choudhary Jain

Chartered Accountant & an experienced credit analyst. She has worked with CRISIL as a Senior Credit Analyst on rating assignments including business & financial analysis in Corporates as well as the Public Finance Sector. Please mail your queries, feedback, and any suggestions to her on info.financepost@gmail.com

Latest posts by CA Priyanka Choudhary Jain (see all)

• One MobiKwik Systems Limited, MobiKwik IPO - 14/10/2021
• Bharti Airtel Rights Issue- Should You Subscribe? - 07/10/2021
• How to Check your IPO Allotment status? - 28/09/2021

Disclaimer: The above content is for general info purpose only and does not constitute professional advice. The author/ website will not be liable for any inaccurate / incomplete information and any reliance you place on the content is strictly at your risk.

Follow us on Social Media by clicking below